摘要
目的试析前列地尔治疗高龄糖尿病并慢性肾脏病患者疗效及安全性。方法选取我院收治的高龄糖尿病并慢性肾脏病患者62例,分为两组,对照组用常规治疗,实验组用前列地尔治疗,分析两组治疗疗效。结果实验组治疗后Cr、24 h UAER改善程度及临床总有效率优于对照组(P<0.05)。结论采用前列地尔治疗高龄糖尿病并慢性肾脏病的效果显著,且安全性高。
Objective Analysis of alprostadil in treatment of elderly patients with diabetes and chronic kidney disease and safety. Methods Selected 62 cases with senile diabetes and chronic kidney disease in our hospital, which were divided into two groups, the control group with conventional therapy, the experimental group with alprostadil, analysis of therapeutic effects of two groups were compared. Results The experimental group after treatment, 24 hours UAER, Cr improvement and clinical total effective rate was better than the control group（P〈0.05）. Conclusion The alprostadil treatment of senile diabetes and chronic kidney disease effect, and high safety.
出处
《中国继续医学教育》
2016年第6期142-143,共2页
China Continuing Medical Education
关键词
前列地尔
治疗
高龄糖尿病
慢性肾脏病
Alprostadil
Therapy
Diabetes mellitus
Chronic kidney disease
